Nitric oxide inhibition in the treatment of septic shock
- 1 October 1995
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 23 (10), 1621-1624
- https://doi.org/10.1097/00003246-199510000-00003
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shockCritical Care Medicine, 1995
- Nitric oxide: basic science and clinical applicationsAnaesthesia, 1994
- Methylene blue reverses endotoxin-induced hypotension.Circulation Research, 1994
- Role of nitric oxide in the hemodynamic changes of sepsisCritical Care Medicine, 1993
- LACK OF PROTECTION BY Nw-METHYL-L-ARGININE (NMA), A NITRIC OXIDE SYNTHASE INHIBITOR, IN ENDOTOXIN (LPS)-CHALLENGED CANINESCritical Care Medicine, 1993
- N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.The Journal of Experimental Medicine, 1992
- Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shockThe Lancet, 1991
- Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the ratBritish Journal of Pharmacology, 1990
- Regional and cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans ratsBritish Journal of Pharmacology, 1990
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987